InCarda Therapeutics Announces Execution of Planned CEO Transition to Drive Next Phase of Corporate Growth
04 oct. 2022 07h00 HE
|
InCarda Therapeutics, Inc.
Robert Lisicki Appointed as New Chief Executive Officer and Board Member; Possesses Broad Commercial and Public Company Experience Grace E, Colón, Ph.D., Stepping Aside Following Nearly Ten Years as...
Heart Tumor Market Size Worth USD 1.36 Billion by 2030 at 8.5% CAGR - Report by Market Research Future (MRFR)
29 sept. 2022 02h30 HE
|
Market Research Future
New York, USA, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Heart Tumor Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Heart Tumor Market Information By...
BioSig Launches PURE EP™ Software Version 6 with ACCUVIZ™ Module
22 sept. 2022 09h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Sept. 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
Introducing Fox & Muse: Integrating Dating, Security, and Luxury
08 sept. 2022 11h00 HE
|
Fox & Muse
AUSTIN, Texas, Sept. 08, 2022 (GLOBE NEWSWIRE) -- On the heels of Tinder Swindler, it's a commonly-known fact that the dating space is saturated with the likes of fakes, scammers, catfish, and...
Global Wearable Cardiac Devices Market Predicted to Register $7,733.1 Million and Grow at 26.5% CAGR by 2027 Post Covid-19 Catastrophe | Research Dive
05 sept. 2022 09h00 HE
|
Research Dive
New York, USA, Sept. 05, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global wearable cardiac devices market is predicted to register a revenue of $7,733.1...
BioSig Strengthens Marketing and Sales Teams, Appoints National Account Executives to Scale Commercial Growth
30 août 2022 09h37 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Company increases sales efforts and strategy, adds new National Account Executives to accelerate commercial growth Strengthens marketing team with...
BioSig Places Second PURE EP™ System For Evaluation at Cleveland Clinic a Leading Medical Center of Excellence
24 août 2022 09h17 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Leading Medical Center of Excellence adds second PURE EP™ System for evaluation, broadening physician access to the Company’s signal processing...
BioSig’s Cardiac Signal Processing Technology To Be Featured at Kansas City Heart Rhythm Symposium 2022
17 août 2022 09h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 17, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company advancing electrophysiology workflow by delivering...
BioSig Sees Positive Momentum from Sales Pipeline Growth
16 août 2022 09h47 HE
|
BioSig Technologies, Inc.
Westport, CT, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Company sees increase in medical centers entering into 60-day evaluation agreements Existing customers seeing positive results from PURE EP™ System...
Defibrillator Market Size is projected to reach USD 21 Billion by 2030, growing at a CAGR of 7.18%: Straits Research
03 août 2022 13h00 HE
|
Straits Research
New York, United States, Aug. 03, 2022 (GLOBE NEWSWIRE) -- A Defibrillator administers a therapeutic shock to a patient's heart in life-threatening circumstances such ventricular fibrillation,...